Section Arrow
Quote
BIO B.NYSE
- Bio-Rad Laboratories
Quotes are at least 15-min delayed:2025/06/28 11:25 EDT
Last
 --
-- (--)
Day High 
-- 
Prev. Close
234.41 
1-M High
250.08 
Volume 
10 
Bid
225.06
Ask
257.2
Day Low
-- 
Open
-- 
1-M Low
250.08 
Market Cap 
6.81B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 250.08 
20-SMA 250.08 
50-SMA 246.46 
52-W High 359.22 
52-W Low 234.41 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-76.53/9.22
Enterprise Value
8.14B
Balance Sheet
Book Value Per Share
245.45
Cash Flow
Cash Flow Yield
0.07
Income Statement
Total Revenue
2.57B
Operating Revenue Per Share
99.97
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AMIXAutonomix Medical Inc2.01+0.76+60.80%-- 
NAOVNanoVibronix Inc1.17+0.3009+34.62%-- 
BFLYButterfly Network1.96-0.06-2.97%-- 
BBLGBone Biologics Corp4.58+0.42+10.10%0.08PE
BSXBoston Scientific Corp106.53+1.95+1.86%76.05PE
Quotes are at least 15-min delayed：2025/06/28 11:25 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.